Image: Traders UnionIllumina shares extend rally as earnings recovery supports biotech outperformance
β’ Illumina shares continued to rise recently as an earnings recovery helped the company and the broader biotech sector outperform the market. β’ The stock rally follows a period of regulatory and market challenges that previously hindered the company's growth. β’ This recovery suggests a shift in investor confidence toward biotech stocks after a period of volatility.
tradersunion.com

